OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial
Nancy Leung, Samuel M. S. Cheng, Carolyn A. Cohen, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e670-e682
Open Access | Times Cited: 10
Nancy Leung, Samuel M. S. Cheng, Carolyn A. Cohen, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e670-e682
Open Access | Times Cited: 10
Showing 10 citing articles:
Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
M. Asante, Martin Ekholm Michelsen, Mithuna Mille Balakumar, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
M. Asante, Martin Ekholm Michelsen, Mithuna Mille Balakumar, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2
Carolyn A. Cohen, Nancy Leung, Prathanporn Kaewpreedee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Carolyn A. Cohen, Nancy Leung, Prathanporn Kaewpreedee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Current Understanding of the Immune Response after COVID-19 Vaccination
Shunbin Ning, Davide Firinu
Vaccines (2024) Vol. 12, Iss. 3, pp. 250-250
Open Access | Times Cited: 1
Shunbin Ning, Davide Firinu
Vaccines (2024) Vol. 12, Iss. 3, pp. 250-250
Open Access | Times Cited: 1
Omicron breakthrough infections after triple‐dose inactivated COVID ‐19 vaccination: A comprehensive analysis of antibody and T‐cell responses
Tiandan Xiang, Xufeng Quan, Hang Jia, et al.
Immunology (2024) Vol. 172, Iss. 2, pp. 313-327
Open Access | Times Cited: 1
Tiandan Xiang, Xufeng Quan, Hang Jia, et al.
Immunology (2024) Vol. 172, Iss. 2, pp. 313-327
Open Access | Times Cited: 1
Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster
Chin Shern Lau, John Thundyil, May Lin Helen Oh, et al.
Antibodies (2022) Vol. 11, Iss. 4, pp. 70-70
Open Access | Times Cited: 6
Chin Shern Lau, John Thundyil, May Lin Helen Oh, et al.
Antibodies (2022) Vol. 11, Iss. 4, pp. 70-70
Open Access | Times Cited: 6
Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants
Yan Wu, Jian Shi, Xiaoxue He, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 3
Yan Wu, Jian Shi, Xiaoxue He, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 3
Bivalent (Omicron BA.5/ancestral) recombinant spike protein vaccine: a promising booster
Ruiqi Zhang, Ivan Fan‐Ngai Hung
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 6, pp. 558-559
Open Access
Ruiqi Zhang, Ivan Fan‐Ngai Hung
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 6, pp. 558-559
Open Access
Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccine
Eunice Y. C. Shiu, Samuel M. S. Cheng, Mario Martín-Sánchez, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126317-126317
Closed Access
Eunice Y. C. Shiu, Samuel M. S. Cheng, Mario Martín-Sánchez, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126317-126317
Closed Access
Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2
Erin Williams, Felipe Echeverri Tribin, Juan Manuel Carreño, et al.
Vaccine (2024) Vol. 43, pp. 126484-126484
Closed Access
Erin Williams, Felipe Echeverri Tribin, Juan Manuel Carreño, et al.
Vaccine (2024) Vol. 43, pp. 126484-126484
Closed Access
Reflections on COVID-19: A Literature Review of SARS-CoV-2 Testing
Chin Shern Lau, Helen May‐Lin Oh, Tar Choon Aw
Vaccines (2024) Vol. 13, Iss. 1, pp. 9-9
Open Access
Chin Shern Lau, Helen May‐Lin Oh, Tar Choon Aw
Vaccines (2024) Vol. 13, Iss. 1, pp. 9-9
Open Access
